Patents by Inventor Anne King

Anne King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20170314079
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: June 22, 2017
    Publication date: November 2, 2017
    Inventors: Raghida BUKHALID, Michael J. FELDHAUS, Anne KING, Neeraj KOHLI, Eric M. KRAULAND, Jeffrey D. KEARNS, Alexey Alexandrovich LUGOVSKOY, Ulrik B. NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20160002339
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: May 28, 2015
    Publication date: January 7, 2016
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Ulrik NIELSEN
  • Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
    Patent number: 9226964
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Grant
    Filed: January 3, 2014
    Date of Patent: January 5, 2016
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Raghida Bukhalid, Michael Feldhaus, Anne King, Neeraj Kohli, Eric Krauland, Jeffrey David Kearns, Alexey A. Lugovskoy, Ulrik Nielsen
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20150376284
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 31, 2015
    Applicant: Adimab, LLC
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Jeffrey David KEARNS, Alexey A. LUGOVSKOY, Ulrik NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20150368361
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 24, 2015
    Applicant: Adimab, LLC
    Inventors: RAGHIDA BUKHALID, MICHAEL FELDHAUS, ANNE KING, NEERAJ KOHLI, ERIC KRAULAND, ULRIK NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20150368346
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 24, 2015
    Applicant: ADIMAB, LLC
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Jeffrey David KEARNS, Alexey A. LUGOVSKOY, Ulrik NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20150368347
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 24, 2015
    Applicant: ADIMAB, LLC
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Jeffrey David KEARNS, Alexey A. LUGOVSKOY, Ulrik NIELSEN
  • Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
    Patent number: 9044460
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: June 2, 2015
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Raghida Bukhalid, Michael Feldhaus, Anne King, Neeraj Kohli, Eric Krauland, Ulrik Nielsen
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20140234314
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: April 30, 2014
    Publication date: August 21, 2014
    Applicant: MERRIMACK PHARMACEUTICALS, INC.
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Jeffrey David KEARNS, Alexey A. LUGOVSKOY, Ulrik NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20140127207
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 8, 2014
    Applicant: MERRIMACK PHARMACEUTICALS, INC.
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND, Jeffrey David KEARNS, Alexey A. LUGOVSKOY, Ulrik NIELSEN
  • ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
    Publication number: 20110287002
    Abstract: Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
    Type: Application
    Filed: May 4, 2011
    Publication date: November 24, 2011
    Applicant: ADIMAB, LLC
    Inventors: Raghida BUKHALID, Michael FELDHAUS, Anne KING, Neeraj KOHLI, Eric KRAULAND
  • Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists
    Patent number: 6221887
    Abstract: The invention relates to the use of certain pharmaceutical compounds as anti-inflammatory agents.
    Type: Grant
    Filed: September 13, 1999
    Date of Patent: April 24, 2001
    Assignee: AstraZeneca AB
    Inventors: Aziz Asghar, Anne King